Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Radical cure of Plasmodium vivax infection applies blood schizontocidal therapy against the acute attack and hypnozoitocidal therapy against later relapse. Chloroquine and primaquine have been used for 60 years in this manner. Resistance to chloroquine by the parasite now requires partnering other b...
Glavni autori: | Sutanto, I, Tjahjono, B, Basri, H, Taylor, W, Putri, F, Meilia, R, Setiabudy, R, Nurleila, S, Ekawati, L, Elyazar, I, Farrar, J, Sudoyo, H, Baird, J |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2013
|
Slični predmeti
-
Primaquine as anti-relapse therapy for Plasmodium vivax
od: Baird, J
Izdano: (1998) -
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
od: Baird, J
Izdano: (2018) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
od: Krudsood, S, i dr.
Izdano: (2008) -
Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria
od: Baird, JK, i dr.
Izdano: (2018) -
Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
od: Llanos-Cuentas, A, i dr.
Izdano: (2019)